Related Experiment Video
Updated: Mar 11, 2026

Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors
Published on: May 17, 2024
[Paraneoplastic neurological syndromes in gynecological malignancies]
Objective:
The demonstration of life-threatening paraneoplastic syndrome with dominant neurological symptomatology in germinal ovarian malignancy.
Design:
Literature review with case report.
Setting:
Department of Gynecology and Obstetrics, Faculty of Medicine Masaryk University and University Hospital Brno.
Methods:
The review outlines the issue of paraneoplastic syndromes. It describes the etiopathogenesis, the range of clinical symptoms, the diagnostic and therapeutic possibilities, along with a relevant case study which focuses on the paraneoplastic neurological symptoms in malignant germinal ovarian tumor.
Conclusion:
Although paraneoplastic symptomatology is rather rare, it constitutes an important part of the clinical picture of malignant tumors. In a number of cases, the paraneoplastic neurological syndrome (PNNS) symptoms precede the actual tumor diagnosis. The awareness of this connection can thus be important in early diagnostics, which in turn can significantly affect a patients prognosis. Another important benefit of familiarity with the symptoms of neurological paraneoplasia is the fact that some PNNS are associated with specific tumors. Interdisciplinary cooperation is necessary in the case of PNNS for early tumor diagnostics. Treatment of the primary tumor is the key in diagnosed malignancies. With effective oncological treatment, adequate regression of paraneoplastic symptoms can be observed.
Related Concept Videos
Disorders of the Female Reproductive System
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists

